Differences in p63 expression in SCCHN tumours of different sub-sites within the oral cavity
- PMID: 21802344
- DOI: 10.1016/j.oraloncology.2011.07.002
Differences in p63 expression in SCCHN tumours of different sub-sites within the oral cavity
Abstract
Squamous cell carcinoma of the head and neck, SCCHN, the sixth most common cancer in the world, comprises tumours of different anatomical sites. The overall survival is low, and there are no good prognostic or predictive markers available. The p53 homologue, p63, plays an important role in development of epithelial structures and has also been suggested to be involved in development of SCCHN. However, most studies on p63 in SCCHN have not taken into account the fact that this group of tumours is heterogeneous in terms of the particular site of origin of the cancer. Mapping and comparing p63 expression levels in tumours and corresponding clinically normal tissue in SCCHN from gingiva, tongue and tongue/floor of the mouth revealed clear differences between these regions. In normal samples from tongue and gingiva, tongue samples showed 2.5-fold higher median p63 expression and also more widespread expression compared to gingival samples. These results emphasise the importance of taking sub-site within the oral cavity into consideration in analyses of SCCHN.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
Expression of p63, COX-2, EGFR and beta-catenin in smokers and patients with squamous cell carcinoma of the head and neck reveal variations in non-neoplastic tissue and no obvious changes in smokers.Int J Oncol. 2005 Dec;27(6):1661-7. Int J Oncol. 2005. PMID: 16273222
-
Decreased expression of the p63 related proteins beta-catenin, E-cadherin and EGFR in oral lichen planus.Oral Oncol. 2008 Jul;44(7):634-8. doi: 10.1016/j.oraloncology.2007.08.001. Epub 2007 Oct 23. Oral Oncol. 2008. PMID: 17936670
-
p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma.Hum Pathol. 2005 Feb;36(2):187-94. doi: 10.1016/j.humpath.2004.12.003. Hum Pathol. 2005. PMID: 15754296
-
Searching for New Targets and Treatments in the Battle Against Squamous Cell Carcinoma of the Head and Neck, with Specific Focus on Tumours of the Tongue.Curr Top Med Chem. 2018;18(3):214-218. doi: 10.2174/1568026618666180116121624. Curr Top Med Chem. 2018. PMID: 29345578 Review.
-
Papillary squamous cell carcinoma of the oral mucosa: a clinicopathologic and immunohistochemical study of 12 cases and literature review.Ann Diagn Pathol. 2013 Feb;17(1):18-21. doi: 10.1016/j.anndiagpath.2012.04.005. Epub 2012 Jun 4. Ann Diagn Pathol. 2013. PMID: 22672806 Review.
Cited by
-
Subsite-based alterations in miR-21, miR-125b, and miR-203 in squamous cell carcinoma of the oral cavity and correlation to important target proteins.J Carcinog. 2012;11:18. doi: 10.4103/1477-3163.104007. Epub 2012 Nov 28. J Carcinog. 2012. PMID: 23230394 Free PMC article.
-
Interplay between ΔNp63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma.Oncotarget. 2017 Mar 28;8(13):21954-21973. doi: 10.18632/oncotarget.15752. Oncotarget. 2017. PMID: 28423539 Free PMC article.
-
Gene expression changes in tumor free tongue tissue adjacent to tongue squamous cell carcinoma.Oncotarget. 2017 Mar 21;8(12):19389-19402. doi: 10.18632/oncotarget.14288. Oncotarget. 2017. PMID: 28038473 Free PMC article.
-
The immune phenotype of tongue squamous cell carcinoma predicts early relapse and poor prognosis.Cancer Med. 2020 Nov;9(22):8333-8344. doi: 10.1002/cam4.3440. Epub 2020 Oct 13. Cancer Med. 2020. PMID: 33047888 Free PMC article.
-
Site-specific gene expression patterns in oral cancer.Head Face Med. 2017 May 10;13(1):6. doi: 10.1186/s13005-017-0138-0. Head Face Med. 2017. PMID: 28486965 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous